Myotonic Dystrophy Confirmed after Cesarean Section

Seung Hyun Kim; Jeongmin Kim; Taehoon Ha; Sungwon Na

doi:10.4266/kjccm.2016.00864

Articles

Page Path: HOME > Acute Crit Care > Volume 32(1); 2017 > Article

Letter to the Editor Neurology Myotonic Dystrophy Confirmed after Cesarean Section: Seung Hyun Kim, Jeongmin Kim, Taehoon Ha, Sungwon Na; Korean Journal of Critical Care Medicine 2017;32(1):81-82.
DOI: https://doi.org/10.4266/kjccm.2016.00864
Published online: February 17, 2017

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea

Correspondence to: Sungwon Na Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2227-4237 Fax: +82-2-312-7185 E-mail: NSWKSJ@yuhs.ac

• Received: October 12, 2016 • Revised: November 22, 2016 • Accepted: November 23, 2016

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

5,719 Views
106 Download

prev next

Full Article

Download PDF

NOTES
REFERENCES

Dear Editor:

We report a case of Myotonic dystrophy (MD) confirmed after cesarean section under general anesthesia. MD is a common neuromuscular disease in adults, and is characterized by myotonia, and myopathy of the voluntary and involuntary muscles. Patients with MD are at high risk during general anesthesia.

A 33-year-old pregnant woman with hydramnios was admitted to the delivery room, and emergency cesarean section was performed under general anesthesia using 40 mg of rocuronium. After the surgery, the anesthesiologist confirmed partial neuromuscular blockade by train-of-four electrical stimulation and neostigmine 1mg was used for reversal of neuromuscular blocking agents. However, as the patient’s self-respiration was continuously weak, sugammadex 200 mg was additionally administered and then the patient was extubated. In the postanesthesia care unit, she was alert and cooperated well, but presented with shallow breathing continuously; and arterial blood sampling revealed respiratory acidosis, hypoventilation, and hypercapnia. Due to diminished consciousness, reintubation was performed, and the patient was admitted to the intensive care unit (ICU). On both the second and third day after ICU admission, she met the spontaneous breathing trial (SBT) safety criteria respectively which consists of inspiratory pressure < –25 cmH₂O, tidal volume > 5 mL/kg, vital capacity > 10 mL/kg, minute ventilation < 10 L/min, and rapid shallow breathing index < 100. Extubations was performed on the second and third day post admission, but each time we had to reintubate the patient because of consistent hypercapnia, shallow breathing, and sequential desaturation within several hours.

For diagnosis, we obtained medical history about the patient’s shallow breathing pattern. Her husband reported that she had “a feeling of weakness” and exhibited upper eyelid drooping in the evening during the third trimester of pregnancy. Gene analysis performed on the seventh day after ICU admission revealed expansion of cytosine-thymine-guanine (CTG) repeats of the dystrophia myotonica protein kinase gene, which could confirm the diagnosis of MD. After the diagnosis of MD, tracheostomy was performed, and she was transferred to the general ward for respiratory rehabilitation treatment.

Our patient did not have a family history of MD and did not present with definite symptoms of muscle wasting. During the preoperative period, the possibility of MD was overlooked, and surgery was performed under general anesthesia. However, after the repeated weaning failure, we could diagnose MD based on the husband’s statement, electromyographic studies, and gene analysis.

The MD gene is located on the long arm of chromosome 19 band 13 q. It codes a protein kinase found in skeletal muscle, where it possibly plays a regulatory role. This gene contains an unstable tri-nucleotide repetition CTG. In normal subjects, the number of repeats ranges from 5 to 34; however, in patients with MD, the CTG pattern is repeated as many as 2,000 times, disrupting the normal function of the protein.[1] Individuals with a repeat size between 35 and 49, designated permutation status, or mutable normal are asymptomatic. A mutation of 50 to approximately 150 CTG repeats is associated with a mild disease phenotype, typically characterized by cataracts and mild myotonia. Age at onset is between 20 and 70 years, and life expectancy is normal or moderately reduced. Longer repeats, in the range of 100 to 1,000, are seen in individuals with the classic MD phenotype (onset between 12 and 30 years of age) with muscle wasting and weakness, myotonia, cataracts, and cardiac conduction defects.[2-4]

Pregnancy is associated with an exacerbation of this myopathy. Major antepartum complications include polyhydramnios, preterm labor, urinary tract infections, and placenta previa. Polyhydramnios of unknown etiology may be the first sign of MD. In our case, genetic analysis revealed 73 CTG repeats, which corresponds to the mild disease phenotype. If MD is diagnosed preoperatively, regional anesthesia may be recommended for cesarean section because patients with MD are particularly sensitive to anesthetics, and intra- and postoperative complications are relatively frequent. However, when general anesthesia is required, monitoring of neuromuscular function appears to be safe and is important in the management of these patients.

In case of a failed SBT, it is important to take a careful history of patient symptoms, and appropriate examination should follow. In patients with neuromuscular disease, trial extubation can be performed when standard readiness criteria are met. In patients in whom extubation is unsuccessful, timely progression to tracheostomy placement can be considered.

NOTES

No potential conflict of interest relevant to this article was reported.

REFERENCES

1. Khan ZA, Khan SA. Myotonic dystrophy and pregnancy. J Pak Med Assoc 2009;59:717-9.PubMed
2. Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52:1164-74.PubMed PMC
3. Dalton JC, Ranum LP, Day JW. GeneReview(R) [Internet]. Seattle (WA), University of Washington; 2006 Chapter 454, Myotonic Dystrophy Type 2; [cited 2006 Sep 21]; [about 26 screens]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1466/
4. Arsenault ME, Prévost C, Lescault A, Laberge C, Puymirat J, Mathieu J. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006;66:1248-50.Article PubMed

Figure & Data

References

Citations

Citations to this article as recorded by

PubReader
ePub Link

Cite

CITE: export Copy Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Myotonic Dystrophy Confirmed after Cesarean Section

Korean J Crit Care Med. 2017;32(1):81-82. Published online February 17, 2017

DOI: https://doi.org/10.4266/kjccm.2016.00864

XML Download

Myotonic Dystrophy Confirmed after Cesarean Section